LFNG

Across TCGA pan-cancer cohorts, LFNG mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated LFNG data layer compared with 27 for mass-spec protein and 3 for mutation status.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where higher LFNG mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated LFNG expression acts as an unfavorable survival marker.

PDAC, HNSC, and LUAD are the cancer types where LFNG mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PDAC	DFS	Median	III,IV	0.346	0.962	.001	40	view →
HNSC	DFS	Quartile	All	0.908	1.000	.034	4	view →
LUAD	OS	Median	All	0.689	0.954	.039	2	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

LFNG–PDAC (DFS)

Open the PDAC breakdown →